Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Trial

BACKGROUND: The optimal treatment for oligometastatic prostate cancer (OMPC) is still on its way. Accumulating evidence has proven the safety and feasibility of radical prostatectomy and local or metastasis-directed radiotherapy for oligometastatic patients. The aim of this trial is to demonstrate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xianzhi, Xiao, Yu-Tian, Yang, Yue, Ye, Yusheng, Chang, Yifan, Jiang, Lingong, Eftekhar, Md, Ren, Shancheng, Zhang, Huojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393665/
https://www.ncbi.nlm.nih.gov/pubmed/35980734
http://dx.doi.org/10.1177/10732748221120462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393665/
https://www.ncbi.nlm.nih.gov/pubmed/35980734
http://dx.doi.org/10.1177/10732748221120462

Ejemplares similares